Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials

BMC Med Res Methodol. 2020 Sep 11;20(1):227. doi: 10.1186/s12874-020-01114-8.

Junhao Liu^{1

2}, Jo Wick¹, Renee' H Martin³, Caitlyn Meinzer³, Dooti Roy⁴, Byron Gajewski⁵

¹ Department of Biostatistics & Data Science, University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.
² Novartis, East Hanover, NJ, 07936, USA.
³ Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA.
⁴ Boehringer Ingelheim, Ridgefield, CT, 06877, USA.
⁵ Department of Biostatistics & Data Science, University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. bgajewski@kumc.edu.

Abstract

An amendment to this paper has been published and can be accessed via the original article.